IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The main focus of the Company is on ophthalmology business. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumentation including laser probes, and are used in the treatment of serious eye diseases. The Company’s ophthalmology business includes repair, servicing and extended service contracts for its laser systems, and a capital component, consisting of the laser consoles combined with durable delivery devices (laser systems). Its laser consoles consist of IQ products, which include IQ 532, IQ 577 and IQ 810 laser photocoagulation systems and OcuLight products including OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLx laser photocoagulation systems.